Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 542-555
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.542
Table 1 Comparative analysis of clinical indicators and spectral computed tomography parameters between groups
VariablesTraining cohort (n = 172)
Validation cohort (n = 85)
LVI/PNI (+)
LVI/PNI (-)
P value
LVI/PNI (+)
LVI/PNI (-)
P value
Gender, n (%)
    Male77 (61.1)49 (38.9)0.81847 (70.2)20 (29.8)0.109
    Female29 (63.0)17 (37.0)9 (50.0)9 (50.0)
Age, yr, n (%)
    < 6033 (66.0)17 (34.0)0.45019 (67.9)9 (32.1)0.788
    ≥ 6073 (59.8)49 (40.2)37 (64.9)20 (35.1)
CT-T
    T1/223 (30.3)53 (69.7)< 0.001a9 (28.1)23 (71.9)< 0.001a
    T3/483 (86.5)13 (13.5)47 (88.7)6 (11.3)
CT-N
    N029 (34.9)54 (65.1)< 0.001a19 (55.8)24 (44.2)< 0.001a
    N1/2/377 (86.5)12 (13.5)36 (12.2)5 (87.8)
CT-EMVI
    Negative44 (41.5)62 (58.5)< 0.001a20 (45.5)24 (54.5)< 0.001a
    Positive62 (6.1)4 (93.9)36 (87.8)5 (12.2)
CA72-4, n (%)
    Negative86 (57.3)64 (42.7)0.002a46 (63.9)26 (36.1)0.528
    Positive20 (90.9)2 (9.1)10 (76.9)3 (23.1)
AFP, n (%)
    Negative104 (61.5)65 (38.5)1.00054 (65.9)28 (34.1)1.000
    Positive2 (66.7)1 (33.3)2 (66.7)1 (33.3)
CEA, n (%)
    Negative91 (61.1)58 (38.9)0.70442 (61.8)26 (38.2)0.109
    Positive15 (65.2)8 (34.8)14 (82.4)3 (17.6)
CA199, n (%)
    Negative89 (58.6)63 (41.4)0.022a48 (64.0)27 (36.0)0.483
    Positive17 (85.0)3 (15.0)8 (80.0)2 (20.0)
CA125, n (%)
    Negative101 (60.5)66 (39.5)0.15854 (65.9)28 (34.1)1.000
    Positive5 (100.0)0 (0.0)2 (66.7)1 (33.3)
VP-70 kev, mean ± SD92.46 ± 18.2964.54 ± 15.90< 0.001a89.87 ± 20.3466.30 ± 18.65< 0.001a
EP-NIC, mean ± SD0.68 ± 0.160.49 ± 0.13< 0.001a0.69 ± 0.150.51 ± 0.12< 0.001a
Table 2 Risk factors of lymphovascular invasion and perineural invasion in gastric cancer
Variables
Feature selection
Individual nomogram
BestFirst with probability (%)
InfoGainAttributeEval with average merit
Z value
OR (95%CI)
P value
CT-EMVI1000.203 ± 0.0162.4513.396 (1.277-9.027)0.014
CT-T1000.263 ± 0.0182.1772.683 (1.103-6.523)0.029
VP-70kev900.356 ± 0.0163.5651.047 (1.021-1.074)< 0.001
EP-NIC900.239 ± 0.0162.934117.723 (4.867-2847.564)0.003
CT-N1000.197 ± 0.014
Table 3 Performance of the individual nomogram and single independent factors

AUC (95%CI)
Sensitivity
Specificity
PPV
NPV
Accuracy
Nomogram
    Training cohort0.918 (0.866-0.954)85.983.389.278.684.9
    Validation cohort0.874 (0.784-0.936)87.575.987.575.983.5
CT-EMVI
    Training cohort0.762 (0.691-0.824)58.593.993.958.572.1
    Validation cohort0.735 (0.628-0.825)64.382.887.854.570.6
CT-T
    Training cohort0.793 (0.725-0.851)78.380.386.569.779.1
    Validation cohort0.816 (0.717-0.892)83.979.388.771.982.4
VP-70kev
    Training cohort0.888 (0.831-0.931)84.971.282.674.679.7
    Validation cohort0.804 (0.703-0.882)92.955.280.080.080.0
EP-NIC
    Training cohort0.824 (0.758-0.877)82.162.177.768.374.4
    Validation cohort0.824 (0.726-0.898)85.758.680.068.076.5